Global, regional and national burden of pancreatic cancer, 1990 to 2017: Results from the Global Burden of Disease Study 2017
Tài liệu tham khảo
Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA A Cancer J Clin, 68, 394, 10.3322/caac.21492
Ilic, 2016, Epidemiology of pancreatic cancer, World J Gastroenterol, 22, 9694, 10.3748/wjg.v22.i44.9694
2018, Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet, 392, 1684, 10.1016/S0140-6736(18)31891-9
2018, Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet, 392, 1736, 10.1016/S0140-6736(18)32203-7
2018, Lancet, 392, 1923, 10.1016/S0140-6736(18)32225-6
2018, Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet, 392, 1859, 10.1016/S0140-6736(18)32335-3
2018, Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet, 392, 1789, 10.1016/S0140-6736(18)32279-7
Foreman, 2012, Modeling causes of death: an integrated approach using CODEm, Popul Health Metrics, 10, 1, 10.1186/1478-7954-10-1
Gao, 2012, Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005, Eur J Epidemiol, 27, 39, 10.1007/s10654-011-9636-8
Liu, 2019, The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention, J Hepatol, 70, 674, 10.1016/j.jhep.2018.12.001
Fitzmaurice, 2018, Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study, Jama Oncol, 4, 1553, 10.1001/jamaoncol.2018.2706
Korc, 2017, Tobacco and alcohol as risk factors for pancreatic cancer, Best Pract Res Clin Gastroenterol, 31, 529, 10.1016/j.bpg.2017.09.001
Liao, 2015, Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis, BMJ, 350, g7371, 10.1136/bmj.g7371
Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Canc, 136, E359, 10.1002/ijc.29210
Raimondi, 2009, Epidemiology of pancreatic cancer: an overview, Nat Rev Gastroenterol Hepatol, 6, 699, 10.1038/nrgastro.2009.177
Lucas, 2016, Global trends in pancreatic cancer mortality from 1980 through 2013 and predictions for 2017, Clin Gastroenterol Hepatol, 14, 1452, 10.1016/j.cgh.2016.05.034
Wong, 2017, Global temporal patterns of pancreatic cancer and association with socioeconomic development, Sci Rep, 7, 3165, 10.1038/s41598-017-02997-2
Maisonneuve, 2015, Risk factors for pancreatic cancer: a summary review of meta-analytical studies, Int J Epidemiol, 44, 186, 10.1093/ije/dyu240
Iodice, 2008, Tobacco and the risk of pancreatic cancer: a review and meta-analysis, Langenbeck’s Arch Surg, 393, 535, 10.1007/s00423-007-0266-2
Ng, 2014, Smoking prevalence and cigarette consumption in 187 countries, 1980-2012, J Am Med Assoc, 311, 183, 10.1001/jama.2013.284692
Maisonneuve, 2019, Epidemiology and burden of pancreatic cancer, Presse Med, 48, e113, 10.1016/j.lpm.2019.02.030
Zhang, 2018, Challenges in diagnosis of pancreatic cancer, World J Gastroenterol, 24, 2047, 10.3748/wjg.v24.i19.2047
Gaujoux, 2019, Pancreatic cancer is still waiting for the big leap forward, Presse Med, 48, e111, 10.1016/j.lpm.2019.02.013
Bouzbid, 2018, Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries, Lancet, S553487375